After the markets closed on Monday, Halozyme released a first quarter 2014 loss of $0.22 per share, greater than our…
On Tuesday, after the markets closed, Genomic Health announced first quarter results that were slightly below expectations, driven in part…
Monday afternoon, CareFusion reported below-plan third-quarter results. Revenue came in at $968 million (up 7% reported and constant currency), $27…
We note that more than 75,000 patients in the United States and Europe develop ALF annually, leading to mortality rates…
After the markets closed on Tuesday, GenMark reported first-quarter results, with revenue of $7.9 million topping our $6.4 million target…
Tuesday afternoon Thoratec reported first-quarter results that exceeded expectations; however, we estimate that when adjusted for the impact of a…